[HTML][HTML] The antimicrobial peptides and their potential clinical applications

J Lei, L Sun, S Huang, C Zhu, P Li, J He… - American journal of …, 2019 - ncbi.nlm.nih.gov
Nowadays, the bacterial drug resistance leads to serious healthy problem worldwide due to
the long-term use and the abuse of traditional antibiotics result in drug resistance of bacteria …

Mini review on antimicrobial peptides, sources, mechanism and recent applications

JK Boparai, PK Sharma - Protein and peptide letters, 2020 - ingentaconnect.com
Antimicrobial peptides in recent years have gained increased interest among scientists,
health professionals and the pharmaceutical companies owing to their therapeutic potential …

Clinical applications and anticancer effects of antimicrobial peptides: from bench to bedside

A Jafari, A Babajani, R Sarrami Forooshani… - Frontiers in …, 2022 - frontiersin.org
Cancer is a multifaceted global health issue and one of the leading causes of death
worldwide. In recent years, medical science has achieved great advances in the diagnosis …

[HTML][HTML] An update on antimicrobial peptides (AMPs) and their delivery strategies for wound infections

V Patrulea, G Borchard, O Jordan - Pharmaceutics, 2020 - mdpi.com
Bacterial infections occur when wound healing fails to reach the final stage of healing, which
is usually hindered by the presence of different pathogens. Different topical antimicrobial …

Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells

J do Nascimento Dias, C de Souza Silva… - Scientific reports, 2020 - nature.com
Candida albicans is a major cause of human infections, ranging from relatively simple to
treat skin and mucosal diseases to systemic life-threatening invasive candidiasis. Fungal …

d-Amino acids in antimicrobial peptides: a potential approach to treat and combat antimicrobial resistance

S Kapil, V Sharma - Canadian journal of microbiology, 2021 - cdnsciencepub.com
Antimicrobial resistance is one of the leading challenges in the human healthcare segment.
Advances in antimicrobial resistance have triggered exploration of natural alternatives to …

Recent strategies for inhibiting multidrug-resistant and β-lactamase producing bacteria: A review

H Fatima, N Goel, R Sinha, SK Khare - Colloids and Surfaces B …, 2021 - Elsevier
Abstract β-lactam antibiotics are one of the most commonly used drugs for treating bacterial
infections, but their clinical effectiveness has been severely affected with bacteria …

In vitro activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-37, fengycin 2B, and magainin-2 against clinically important bacteria

LB Denardi, P de Arruda Trindade, C Weiblen… - Brazilian journal of …, 2022 - Springer
We investigated the antibacterial activity of the antimicrobial peptides h-Lf1-11, MSI-78, LL-
37, fengycin 2B, and magainin-2. The minimum inhibitory concentration (MIC) was …

Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs against Acinetobacter baumannii

MJ Hong, MK Kim, Y Park - International journal of molecular sciences, 2021 - mdpi.com
An amphipathic α-helical peptide, Hp1404, was isolated from the venomous gland of the
scorpion Heterometrus petersii. Hp1404 exhibits antimicrobial activity against methicillin …

Antimalarial agents as therapeutic tools against toxoplasmosis—a short bridge between two distant illnesses

A Secrieru, ICC Costa, PM O'Neill, MLS Cristiano - Molecules, 2020 - mdpi.com
Toxoplasmosis is an infectious disease with paramount impact worldwide, affecting many
vulnerable populations and representing a significant matter of concern. Current therapies …